---
title: "NEXGEL, Inc. (NXGL.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NXGL.US.md"
symbol: "NXGL.US"
name: "NEXGEL, Inc."
industry: "Health Care Supplies"
datetime: "2026-05-20T07:40:35.837Z"
locales:
  - [en](https://longbridge.com/en/quote/NXGL.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NXGL.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NXGL.US.md)
---

# NEXGEL, Inc. (NXGL.US)

## Company Overview

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions.

| Item | Detail |
|------|--------|
| Industry | Health Care Supplies |
| Exchange | US Market |
| Website | [nexgel.com](https://nexgel.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:13.000Z

**Overall: C (0.51)**

**Industry**: Health Care Supplies

| Metric | Value |
|--------|-------|
| Industry Ranking | 34 / 45 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 10.14% |  |
| Net Profit YoY | -2.39% |  |
| P/B Ratio | 1.30 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5203227.93 |  |
| Revenue | 11265000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -69.87% | E |
| Profit Margin | -28.54% | E |
| Gross Margin | 40.04% | B |
| Revenue YoY | 10.14% | B |
| Net Profit YoY | -2.39% | C |
| Total Assets YoY | 11.12% | B |
| Net Assets YoY | -19.50% | E |
| Cash Flow Margin | 44.01% | C |
| OCF YoY | 10.14% | B |
| Turnover | 1.02 | A |
| Gearing Ratio | 61.36% | D |

```chart-data:radar
{
  "title": "Longbridge Financial Score - NEXGEL, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "10.14%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-2.39%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.30",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "5203227.93",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "11265000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "-69.87%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-28.54%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "40.04%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "10.14%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-2.39%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "11.12%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "-19.50%",
          "rating": "E"
        },
        {
          "name": "Cash Flow Margin",
          "value": "44.01%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "10.14%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "1.02",
          "rating": "A"
        },
        {
          "name": "Gearing Ratio",
          "value": "61.36%",
          "rating": "D"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.62 | 27/45 | - | - | - |
| PB | 1.30 | 13/45 | 4.08 | 2.89 | 1.63 |
| PS (TTM) | 0.46 | 4/45 | 1.77 | 1.28 | 0.73 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Essilor (ESLOY.US) | B | B | C | B | B | B |
| 02 | HOYA Corporation (HOCPY.US) | A | C | B | A | B | B |
| 03 | Align (ALGN.US) | B | C | B | B | C | B |
| 04 | Lantheus (LNTH.US) | A | C | B | C | C | B |
| 05 | Merit Medical (MMSI.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-18T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Overweight | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.61 |
| Highest Target | 2.00 |
| Lowest Target | 2.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/NXGL.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/NXGL.US/norm.md)
- [Related News](https://longbridge.com/en/quote/NXGL.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/NXGL.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**